🇺🇸 FDA
Pipeline program

AK0529

AK0529-1003

Phase 2 small_molecule completed

Quick answer

AK0529 for RESPIRATORY SYNCYTIAL VIRUS INFECTIONS is a Phase 2 program (small_molecule) at Shanghai University of Traditional Chinese Medicine with 1 ClinicalTrials.gov record(s).

Program details

Company
Shanghai University of Traditional Chinese Medicine
Indication
RESPIRATORY SYNCYTIAL VIRUS INFECTIONS
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials